Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36473143

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Apr 20
First author
Haddad RI

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Apr 20;41(12):2134-2137. doi: 10.1200/JCO.22.02349.
    note
    Source null
    related pmid
    36877893
    relationship
    Comment in

Authors and identifiers

  1. name
    Haddad RI
    type
    Author
  2. name
    Harrington K
    type
    Author
  3. name
    Tahara M
    type
    Author
  4. name
    Ferris RL
    type
    Author
  5. name
    Gillison M
    type
    Author
  6. name
    Fayette J
    type
    Author
  7. name
    Daste A
    type
    Author
  8. name
    Koralewski P
    type
    Author
  9. name
    Zurawski B
    type
    Author
  10. name
    Taberna M
    type
    Author
  11. name
    Saba NF
    type
    Author
  12. name
    Mak M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Haddad RI
    type
    Author
  2. name
    Harrington K
    type
    Author
  3. name
    Tahara M
    type
    Author
  4. name
    Ferris RL
    type
    Author
  5. name
    Gillison M
    type
    Author
  6. name
    Fayette J
    type
    Author
  7. name
    Daste A
    type
    Author
  8. name
    Koralewski P
    type
    Author
  9. name
    Zurawski B
    type
    Author
  10. name
    Taberna M
    type
    Author
  11. name
    Saba NF
    type
    Author
  12. name
    Mak M
    type
    Author
bibliography ids
  1. nci-bib-949dd709ccc2b1509fda988e
book metadata
content sha256
95761ac71b0a93d2c04b4c2167be751bb2866fa47ba389fcd423b8f0f0bd8f10
document type
citation
dois
  1. 10.1200/JCO.22.00332
electronic publication date
display
2022 Dec 6
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:36473143
immutable id
pubmed:36473143@95761ac71b0a93d2c04b4c2167be751bb2866fa47ba389fcd423b8f0f0bd8f10
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
12
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2166-2180
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Apr 20;41(12):2134-2137. doi: 10.1200/JCO.22.02349.
    note
    Source null
    related pmid
    36877893
    relationship
    Comment in
outcomes validated
false
pmid
36473143
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
9c1e7315a32c37d600caaa8e91d256521b605dd5a37e96ee5a4006387067c4b9
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Apr 20
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36473143/
title
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.

Preserved source evidence · Not medical advice